ALPHARETTA, Ga. (AP) — ALPHARETTA, Ga. (AP) — Alimera Sciences Inc. (ALIM) on Tuesday reported a loss of $3.3 million in its second quarter.
On a per-share basis, the Alpharetta, Georgia-based company said it had a loss of 6 cents.
The eye drug developer posted revenue of $27 million in the period.
Alimera Sciences shares have risen 28% since the beginning of the year. The stock has increased 68% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ALIM at https://www.zacks.com/ap/ALIM
